Thomas Byrne

Thomas Byrne

Auto-generated profile, based on publicly available information

Thomas Byrne

Institute of Health Informatics, University College London, 222 Euston Road, London, NW1 2DA, United Kingdom, 44 02035495969

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2021 in Housing Studies
Verified
Journal Article
Closed access
TBThomas Byrne
Thomas Byrne
MHMinda Huang
Minda Huang
RNRichard E. Nelson
Richard E. Nelson
JTJack Tsai
Jack Tsai
Rapid rehousing (RRH), a programmatic approach that seeks to help households currently experiencing homelessness quickly regain stable housing, has garnered increasing attention over the past decade in the United States and internationally. However, there has been no attempt to assess evidence of the effectiveness of RRH. We address this gap by conducting a systematic review to assess the overall quality of evidence on the impact of RRH; summarize evidence of the effectiveness of RRH on housing, health, social, economic and other outcomes; and summarize evidence regarding whether the effectiveness of RRH varies as a function of the characteristics of persons receiving RRH. We rate the overall methodological rigour of evidence on the impact of RRH as moderate. We find mixed evidence about the impact of RRH as compared to usual care and other housing interventions, and no evidence of a differential impact of RRH depending on recipient characteristics. We discuss how future research might help guide the provision of RRH.

9 November 2021 in medRxiv
Verified
Preprint
Open access
PDF file
RARobert W Aldridge
Robert W Aldridge
AYAlexei Yavlinsky
Alexei Yavlinsky
VNVincent Nguyen
Vincent Nguyen
MEMax T Eyre
Max T Eyre
MSMadhumita Shrotri
Madhumita Shrotri
OSon behalf of the Virus Watch study
on behalf of the Virus Watch study
Background SARS-CoV-2 vaccines stimulate production of antibodies targeting the spike protein (anti-S). The level of antibodies following vaccination and trajectories of waning may differ between vaccines influencing the level of protection, how soon protection is reduced and, consequently the optimum timing of booster doses. Methods We measured SARS-CoV-2 anti-S titre in the context of seronegativity for SARS-CoV-2 anti-Nucleocapsid (anti-N), in samples collected between 1st July and 24th October 2021 in a subset of adults in the Virus Watch community cohort. We compared anti-S levels after BNT162b2 (BioNTech/Pfizer) or ChAdOx1 (AstraZeneca/Oxford) vaccination using time since second dose of vaccination, age, sex and clinical vulnerability to investigate antibody waning. To investigate the use of anti-S levels as a correlate of protection against SARS-CoV-2 infection, we undertook a survival analysis (Kaplan-Meier and Cox) with individuals entering 21 days after their second dose of vaccine, or first antibody test after 1st July (whichever was latest) and exiting with the outcome of SARS-Cov-2 infection or at the end of follow up 24th October 2021. We also undertook a negative test design case-control analysis of infections occurring after the second vaccine dose (breakthrough infections) to determine whether the type of vaccine affected the risk of becoming infected. Results 24049 samples from 8858 individuals (5549 who received a second dose of ChAdOx1 and 3205 BNT162b2) who remained anti-N negative were included in the analysis of anti-S waning over time. Three weeks after the second dose of vaccine BNT162b2 mean anti-S levels were 9039 (95%CI: 7946-10905) U/ml and ChadOx1 were 1025 (95%CI: 917-1146) U/ml. For both vaccines, waning anti-S levels followed a log linear decline from three weeks after the second dose of vaccination. At 20 weeks after the second dose of vaccine, the mean anti-S levels were 1521 (95%CI: 1432-1616) U/ml for BNT162b2 and 342 (95%CI: 322-365) U/ml for ChadOx1. We identified 197 breakthrough infections and found a reduced risk of infection post second dose of vaccine for individuals with anti-S levels greater than or equal to 500 U/ml compared to those with levels under 500 U/ml (HR 0.62; 95%CIs:0.44-0.87; p=0.007). Time to reach an anti-S threshold of 500 U/ml was estimated at 96 days for ChAdOx1 and 257 days for BNT162b2. We found an increased risk of a breakthrough infection for those who received the ChAdOx1 compared to those who received BNT162b2 (OR: 1.43, 95% CIs:1.18-1.73, p<0.001). Discussion Anti-S levels are substantially higher following the second dose of BNT162b2 compared to ChAdOx1. There is a log linear waning in levels for both vaccines following the second dose. Anti-S levels are an important correlate of protection as demonstrated by those with anti-S levels < 500U/ml following vaccination being at significantly greater risk of subsequent infection. Since anti-S levels are substantially lower in ChAdOx1 than in BNT162b2 and both decline at similar rates we would expect waning immunity to occur earlier in ChAdOx1 compared to BNT162b2. Our results showing an increased risk of breakthrough infections for those who were vaccinated with ChAdOx1 compared to BNT162b2 are in line with this hypothesis. Consistent with our data, national analyses of vaccine effectiveness also suggest that waning of immunity for infection and, to a lesser extent for severe disease, is seen earlier in ChAdOx1 than in BNT162b2. Our data demonstrate the importance of booster doses to maintain protection in the elderly and clinically vulnerable and suggest that these should be prioritised to those who received ChAdOx1 as their primary course.

1 November 2021 in Vaccine
Verified
Journal Article
Open access
TBThomas Byrne
Thomas Byrne
PPParth Patel
Parth Patel
MSMadhumita Shrotri
Madhumita Shrotri
SBSarah Beale
Sarah Beale
SMSusan Michie
Susan Michie
RGRichard Gilson
Richard Gilson
Vaccination intention is key to the success of any vaccination programme, alongside vaccine availability and access. Public intention to take a COVID-19 vaccine is high in England and Wales compared to other countries, but vaccination rate disparities between ethnic, social and age groups has led to concern. Online survey of prospective household community cohort study participants across England and Wales (Virus Watch). Vaccination intention was measured by individual participant responses to ‘Would you accept a COVID-19 vaccine if offered?’, collected in December 2020 and February 2021. Responses to a 13-item questionnaire collected in January 2021 were analysed using factor analysis to investigate psychological influences on vaccination intention. Survey response rate was 56% (20,785/36,998) in December 2020 and 53% (20,590/38,727) in February 2021, with 14,880 adults reporting across both time points. In December 2020, 1,469 (10%) participants responded ‘No’ or ‘Unsure’. Of these people, 1,266 (86%) changed their mind and responded ‘Yes’ or ‘Already had a COVID-19 vaccine’ by February 2021. Vaccination intention increased across all ethnic groups and levels of social deprivation. Age was most strongly associated with vaccination intention, with 16–24-year-olds more likely to respond “Unsure” or “No” versus “Yes” than 65–74-year-olds in December 2020 (OR: 4.63, 95 %CI: 3.42, 6.27 & OR 7.17 95 %CI: 4.26, 12.07 respectively) and February 2021 (OR: 27.92 95 %CI: 13.79, 56.51 & OR 17.16 95 %CI: 4.12, 71.55). The association between ethnicity and vaccination intention weakened, but did not disappear, over time. Both vaccine- and illness-related psychological factors were shown to influence vaccination intention. Four in five adults (86%) who were reluctant or intending to refuse a COVID-19 vaccine in December 2020 had changed their mind in February 2021 and planned to accept, or had already accepted, a vaccine.

15 December 2021 in medRxiv
Verified
Preprint
Open access
PDF file
SBSarah Beale
Sarah Beale
SHSusan J Hoskins
Susan J Hoskins
TBThomas Edward Byrne
Thomas Edward Byrne
WFWing Lam Erica Fong
Wing Lam Erica Fong
EFEllen Fragaszy
Ellen Fragaszy
AHAndrew Hayward
Andrew Hayward
Background: Workers differ in their risk of SARS-CoV-2 infection according to their occupation, but the direct contribution of occupation to this relationship is unclear. This study aimed to investigate how infection risk differed across occupational groups in England and Wales up to April 2022, after adjustment for potential confounding and stratification by pandemic phase. Methods: Data from 15,190 employed/self-employed participants in the Virus Watch prospective cohort study were used to generate risk ratios for virologically- or serologically-confirmed SARS-CoV-2 infection using robust Poisson regression, adjusting for socio-demographic and health-related factors and non-work public activities. We calculated attributable fractions (AF) amongst the exposed for belonging to each occupational group based on adjusted risk ratios (aRR). Findings: Increased risk was seen in nurses (aRR=1.44, 1.25-1.65; AF=30%, 20-39%), doctors (aRR=1.33, 1.08-1.65; AF=25%, 7-39%), carers (1.45, 1.19-1.76; AF=31%, 16-43%), primary school teachers (aRR=1.67, 1.42-1.96; AF=40%, 30-49%), secondary school teachers (aRR=1.48, 1.26-1.72; AF=32%, 21-42%), and teaching support occupations (aRR=1.42, 1.23-1.64; AF=29%, 18-39%) compared to office-based professional occupations. Differential risk was apparent in the earlier phases (Feb 2020 - May 2021) and attenuated later (June - October 2021) for most groups, although teachers and teaching support workers demonstrated persistently elevated risk across waves. Interpretation: Occupational differentials in SARS-CoV-2 infection risk vary over time and are robust to adjustment for socio-demographic, health-related, and non-workplace activity-related potential confounders. Direct investigation into workplace factors underlying elevated risk and how these change over time is needed to inform occupational health interventions.

7 December 2022 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
SHSusan Hoskins
Susan Hoskins
SBSarah Beale
Sarah Beale
VNVincent Nguyen
Vincent Nguyen
YBYamina Boukari
Yamina Boukari
AYAlexei Yavlinsky
Alexei Yavlinsky
AHAndrew Hayward
Andrew Hayward
Purpose: We aimed to understand which non-household activities increased infection odds and contributed greatest to SARS-CoV-2 infections following the lifting of public health restrictions in England and Wales. Procedures: We undertook multivariable logistic regressions assessing the contribution to infections of activities reported by adult Virus Watch Community Cohort Study participants. We calculated adjusted weighted population attributable fractions (aPAF) estimating which activity contributed greatest to infections. Findings: Among 11 413 participants (493 infections), infection was associated with: leaving home for work (aOR 1.35 (1.11–1.64), aPAF 17%), public transport (aOR 1.27 (1.04–1.57), aPAF 12%), shopping once (aOR 1.83 (1.36–2.45)) vs. more than three times a week, indoor leisure (aOR 1.24 (1.02–1.51), aPAF 10%) and indoor hospitality (aOR 1.21 (0.98–1.48), aPAF 7%). We found no association for outdoor hospitality (1.14 (0.94–1.39), aPAF 5%) or outdoor leisure (1.14 (0.82–1.59), aPAF 1%). Conclusion: Essential activities (work and public transport) carried the greatest risk and were the dominant contributors to infections. Non-essential indoor activities (hospitality and leisure) increased risk but contributed less. Outdoor activities carried no statistical risk and contributed to fewer infections. As countries aim to ‘live with COVID’, mitigating transmission in essential and indoor venues becomes increasingly relevant.

17 March 2025 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
GGGiorgio Di Gessa
Giorgio Di Gessa
MBMikaela Bloomberg
Mikaela Bloomberg
RSRina So
Rina So
SSShaun Scholes
Shaun Scholes
TBThomas Byrne
Thomas Byrne
PZPaola Zaninotto
Paola Zaninotto
Background: Although air pollution is associated with worse cognitive performance, whether these relationships differ by cognitive domain and which sources of air pollution are particularly detrimental to cognition remains understudied. This study examined associations between cognitive scores across 3 domains in older adults and 8–10 years of exposure to air pollutants (NO2, total PM2.5, and PM2.5 from different emission sources). Methods: We used data from the 2018 Harmonized Cognitive Assessment Protocol substudy of the English Longitudinal Study of Ageing (N = 1 127). Outdoor concentrations of each pollutant were estimated for 2008/2010–2017 and summarized using means and group-based trajectories. Linear regression models were used to assess long-term air pollution exposure relationships with memory, executive function, language, and global cognitive function after adjustment for key individual and neighborhood-level confounders. Results: Associations between air pollution trajectories and cognition are mostly inverted j-shaped, with respondents exposed to the highest residential levels of NO2 and total PM2.5 having worse performance for global cognition (β = −.241; 95% CI = [−0.46, −0.02] and β = −.334; 95% CI = [−0.55, −0.12], respectively) than those exposed to average levels of pollution. Similar associations were also found for executive function and memory (PM2.5 only), whereas more compelling dose–response evidence was found for language. Higher emissions from industry and residential combustion, as well as biofuel, coal, and oil and natural gas combustion, were associated with worse language scores. Conclusions: Air pollution and its sources have domain-specific associations with cognitive performance, with most consistent evidence observed for language. Continued efforts to reduce air pollution, particularly where levels are the highest, might benefit cognitive performance.